Navigation Links
Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ -- Advanced Magnetics today announced that data from three completed Phase III multi- center clinical studies of ferumoxytol as an intravenous iron replacement therapeutic will be presented during the National Kidney Foundation (NKF) 2007 Spring Clinical Meetings taking place April 10th through 14th in Orlando, Florida. Two posters containing the data are scheduled to be presented on Wednesday, April 11, 2007 at approximately 5:30 pm ET.

One poster will include data from the company's two completed studies in non dialysis-dependent chronic kidney disease (NDD-CKD) patients. The company plans to present additional data from its first NDD-CKD study, protocol 62,745-6, for which initial data was presented at the American Society of Nephrology Renal Week 2006 Annual Meeting in November 2006. This safety and efficacy study enrolled 304 NDD-CKD patients who were randomized to receive either two 510 mg doses of ferumoxytol within one week or 200 mg of oral iron daily for three weeks. The primary endpoint in the study was the mean change in hemoglobin from baseline in the ferumoxytol group compared to that in the oral iron treatment group. Results from the second NDD-CKD study, protocol 62,745-7, which completed enrollment in November 2006 will also be presented in this poster. This safety and efficacy study also enrolled 304 NDD-CKD patients who were randomized to receive either two 510 mg doses of ferumoxytol within one week or 200 mg of oral iron daily for three weeks. The primary endpoint in the study was also the mean change in hemoglobin from baseline in the ferumoxytol group compared to that in the oral iron treatment group.

The second poster will include data from the company's large scale safety study in both dialysis-dependent (DD-CKD) and NDD-CKD patients, protocol 62,745-8, which completed enrollment in September 2006. This study enrolled
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer

Post Your Comments:
(Date:11/25/2009)...ov.25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES ),an...residentandCEO,andKeithSchneck,theCompany,sExecuti...stAnnualPiperJaffrayHealthCareConferenceat1:30PMES...restedpartiesmayaccessthepresentationbyvisitingthe...ewebcastmayalsobeaccessedat http://www.corporate-i...
(Date:11/25/2009)...Fla.,Nov.25/PRNewswire-FirstCall/--Formanyofthemil...lionlivingwithuntreated hearingloss ,theholidaysma..., Dr.Beyer,seniorvicepresidentofHearUSA(Amex: EAR ...companies,saidstudieshavelinkedhearinglosstostress...ntensifiedatholidaygatheringswithfamiliesandfriend...
(Date:11/25/2009)...ov.25/PRNewswire-Asia-FirstCall/--ChinaSkyOne,Medi...q: CSKI ),a,leadingfullyintegratedpharmaceuticalco...nthePeople,sRepublicofChina("PRC"),today,announced...itutefor,theControlofPharmaceuticalandBiologicalPr...itsDiagnosticKitforHumanProstateSpecific,Antigen(C...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Sleepy Drivers a Menace on the Road 60687 1Sleepy Drivers a Menace on the Road 60687 2Sg2 Announces Its INSIGHT System to Improve Hospitals 26apos 3B Clinical Performance and Bottom Line Results 60683 1Sg2 Announces Its INSIGHT System to Improve Hospitals 26apos 3B Clinical Performance and Bottom Line Results 60683 2Sg2 Announces Its INSIGHT System to Improve Hospitals 26apos 3B Clinical Performance and Bottom Line Results 60683 3Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care De 60679 1Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care De 60679 2Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care De 60679 3Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care De 60679 4
...n highly potent DPP-4 inhibitor, possessing Ki of ...ph Pharmaceuticals,Inc., a privately held drug di... the results of its potent, smart DPP-4 inhibitor,...erican Diabetes,Association meeting in Chicago, Il...remely long acting, potent inhibitor of DPP-4 and,...
...Change Reported Unlike What Is Commonly Seen In,In...FirstCall/ -- Novo Nordisk,today announced results...ty and efficacy of insulin Levemir(R) (insulin det...2 diabetes were able,to adjust their own dosage of...r, comparable to dosing adjusted by their primary ...
Other Medicine Technology:Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5
(Date:11/25/2009)...,, EDINA,Minn.,Nov.25/PRNewswire-USNewswire/...dentist.Butachiropractorcanalsogivepatientsthehelp...hichiswhereyourjaw(mandible)contacts/connectswithy...sassociatedwithTMJdysfunctionarepainwithchewing,cl...ausedfromTMJdysfunctionincluding:headaches,fatigue...
(Date:11/25/2009)...,, EMERYVILLE,Calif.,Nov.25/PRNewswire-First...dayannouncedthatthecompanywillhosttwoinvestorevent...r7,2009-9:00a.m.CT/10:00a.m.ET ,, Principalin...carfilzomibinrelapsedand/orrefractorymultiplemyelo...ASH)AnnualMeetingandExpositioninNewOrleans,LA.Thet...
(Date:11/25/2009)...,, TORONTO,Nov.25/PRNewswire/-SentinelleMedi...ancedvisualizationsoftwarelaunchesasuiteofnewleadi...gingsoftwareplatformatthisyear,sRadiologicalSociet...-Dec.5,2009(Booth5800,HallA).Theapplicationslevera...sspecializedMRIimagingcoilsandsupportmultipleimagi...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNews...FDA,sCenterforDrugEvaluationandResearch,titled"ADi...,"appearsintheNov.26,2009issueofTheNewEnglandJourn...cgi-bin/prnh/20090824/FDALOGO ) ,, Inthearticle...naccesstopainmedicationforthosewhoneeditandmanagin...
(Date:11/25/2009)...,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayAr...first Winter Spare the Air Alert for...acturedfirelogsoranyothersolidfuel,bothindoorsando...nhealthyairqualitytomorrow,"saidJackBroadbent,exec...sidentstorespectthehealthoftheirneighborsandfellow...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...y Over Estimated A UK doctor, and a leading exp...s in children are being overstated, leading to unn...m the University of Newcastle upon Tyne said there...ng in the British Medical Journal, he said that ov...
...ys that breastfeeding in the US depends on what cl...fessional backgrounds// are allowed to breastfeed ... "I feel like I had to choose between feeding...r breaks behind a fridge or the toilet in order to...
...s show that drug deaths in Scotland have dropped t... drugs in Scotland in 2005 compared with 356 in 20...e is a tragedy and reminds us that drug abuse is a...ures for drug-related deaths have fallen but we ca...
...rpses in polythene bags and burying people who hav...theastern Indian state of Mizoram has outraged peo...king to find people in some parts of the state pac... with HIV/AIDS Society, told IANS. With a l...
...a special committee to check cases of polio that h...first week of August the country reported 155 case...tar Pradesh, the country's most populous state. ...h Minister Ambumani Ramadoss told IANS on the side...
...to doing well in school because your child will be...ile doing homework.// While this is common sense, ...an be complex; and the rewards for treatment can e...Robin A. Dyleski, MD director of Pediatric Otolary...
Other Medicine News:Health News:Strange Burial Practice Followed for People Affected by HIV/AIDS 2
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
Medicine Products: